Citius Oncology, Inc. Common Stock (CTOR)

Typically moves ±5.84% on earnings
EARNINGS ANALYTICS
search

Citius Oncology, Inc. Common Stock (CTOR) has reported earnings 6 times since Dec 27, 2024. The stock moves an average of ±5.84% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +5.62% (Aug 12, 2025) and its largest decline was -16.78% (May 15, 2026).

Earnings reactions

How CTOR moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

6

Avg Abs. Movement

±5.84%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 15, 2026 ☽ POST -16.78% open_in_new
Feb 13, 2026 ☀ PRE +1.69% open_in_new
Dec 23, 2025 ☽ POST -9.84% open_in_new
Aug 12, 2025 ☽ POST +5.62% open_in_new
event

Earnings Count

6

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.84%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 5 →
5
Funds holding
$2458333
Total value held
Buying
3 added · 0 reduced
Bank Of America Corp /De/
$2373964 +1792030.84%
Blackrock, Inc.
$29417 +112.38%
Northern Trust Corp
$28358 Held
State Street Corp
$26594 Held
Royal Bank Of Canada
$0 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
EFFECT 20260605 open_in_new SEC.gov
SCHEDULE 13D/A 20260604 open_in_new SEC.gov
424B3 20260601 open_in_new SEC.gov
8-K 20260601 open_in_new SEC.gov
DEF 14C 20260529 open_in_new SEC.gov
S-3 20260529 open_in_new SEC.gov
424B3 20260522 open_in_new SEC.gov
PRE 14C 20260519 open_in_new SEC.gov
10-Q 20260515 open_in_new SEC.gov
8-K 20260515 open_in_new SEC.gov

Frequently asked about CTOR earnings

How much does CTOR stock move after earnings? expand_more

Over 6 reports, CTOR has moved an average of ±5.84% the session after earnings, closing higher 50.0% of the time.

What was CTOR's biggest post-earnings move? expand_more

CTOR's largest post-earnings gain on record was +5.62% on Aug 12, 2025, and its largest decline was -16.78% on May 15, 2026.

Where can I find Citius Oncology, Inc. Common Stock's SEC filings? expand_more

All of Citius Oncology, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers